LECONTE MEDICAL CENTER — History
CCN 440081 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$126M
Latest Revenue (FY2022)
+6.8%
Revenue CAGR (3yr)
6.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $111M | $125M | $126M | +0.6% | +6.8% |
| Operating Expenses | $103M | $114M | $118M | +3.6% | +6.9% |
| Operating Margin | 6.6% | 9.1% | 6.4% | -29.7% | -2.0% |
| Net Income | $7M | $11M | $8M | -29.3% | +4.7% |
| Licensed Beds | 60 | 60 | 60 | +0.0% | +0.0% |
| Total Patient Days | 16,915 | 21,096 | 18,250 | -13.5% | +3.9% |
| Medicare Day % | 23% | 20% | 20% | +1.2% | -7.2% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +14.0% ($111M → $126M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.8%
This Hospital
+7.6%
State Avg
Latest Margin
6.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $134M | 6.2% |
| FY2024 (proj) | $142M | 6.1% |
| FY2025 (proj) | $150M | 6.0% |